Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9057)
All Articles published online
|
Jan 7, 2013 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zelber-Sagi S, Webb M, Assy N, Blendis L, Yeshua H, Leshno M, Ratziu V, Halpern Z, Oren R, Santo E. Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification. World J Gastroenterol 2013; 19(1): 57-64 [PMID: 23326163 DOI: 10.3748/wjg.v19.i1.57] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i1/57.htm |
| Number | Citing Articles |
| 1 |
Eduardo Vilar-Gomez, Raj Vuppalanchi, Samer Gawrieh, Francis Pike, Niharika Samala, Naga Chalasani. Significant Dose-Response Association of Physical Activity and Diet Quality With Mortality in Adults With Suspected NAFLD in a Population Study. American Journal of Gastroenterology 2023; 118(9): 1576 doi: 10.14309/ajg.0000000000002222
|
| 2 |
Jessica Bazick, Michele Donithan, Brent A. Neuschwander-Tetri, David Kleiner, Elizabeth M. Brunt, Laura Wilson, Ed Doo, Joel Lavine, James Tonascia, Rohit Loomba. Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD. Diabetes Care 2015; 38(7): 1347 doi: 10.2337/dc14-1239
|
| 3 |
Artem Kaliaev, Wilson Chavez, Jorge Soto, Fahimul Huda, Hua Xie, Man Nguyen, Vijay Shamdasani, Stephan Anderson. Quantitative Ultrasound Assessment of Hepatic Steatosis. Journal of Clinical and Experimental Hepatology 2022; 12(4): 1091 doi: 10.1016/j.jceh.2022.01.007
|
| 4 |
Daniel J Cuthbertson, Martin O Weickert, Daniel Lythgoe, Victoria S Sprung, Rebecca Dobson, Fariba Shoajee-Moradie, Margot Umpleby, Andreas F H Pfeiffer, E Louise Thomas, Jimmy D Bell, Helen Jones, Graham J Kemp. External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals. European Journal of Endocrinology 2014; 171(5): 561 doi: 10.1530/EJE-14-0112
|
| 5 |
Daqing Piao, Jerry W. Ritchey, G. Reed Holyoak, Corey R. Wall, Nigar Sultana, Jill K. Murray, Kenneth E. Bartels. In vivo percutaneous reflectance spectroscopy of fatty liver development in rats suggests that the elevation of the scattering power is an early indicator of hepatic steatosis. Journal of Innovative Optical Health Sciences 2018; 11(04) doi: 10.1142/S1793545818500190
|
| 6 |
Alvaro Rivera‐Andrade, Jessica L. Petrick, Christian S. Alvarez, Barry I. Graubard, Andrea A. Florio, Maria F. Kroker‐Lobos, Dominick Parisi, Neal D. Freedman, Mariana Lazo, Eliseo Guallar, John D. Groopman, Manuel Ramirez‐Zea, Katherine A. McGlynn. Circulating bile acid concentrations and non‐alcoholic fatty liver disease in Guatemala. Alimentary Pharmacology & Therapeutics 2022; 56(2): 321 doi: 10.1111/apt.16948
|
| 7 |
Chuanlei Fan, Yang He, Jian Yang, Mingxu Da. Association Between Live Microbe Intake and NAFLD: Evidence From NHANES 2003–2018. Journal of the American Nutrition Association 2024; 43(3): 272 doi: 10.1080/27697061.2023.2270537
|
| 8 |
Monica C. Preciado-Puga, Yeniley Ruiz-Noa, Juana R. Garcia-Ramirez, Benjamin Jordan-Perez, Serafin Garnelo-Cabañas, Maria L. Lazo de la Vega-Monroy, Karen I. Gutierrez-Aguirre, Lorena R. Ibarra-Reynoso. Non-invasive diagnosis of non-alcoholic fatty liver disease using an algorithm combining clinical indexes and ultrasonographic measures. Annals of Hepatology 2021; 21: 100264 doi: 10.1016/j.aohep.2020.09.008
|
| 9 |
Tae-In Hwang, A-Lum Han. Quality of Life in Adults with Metabolic Dysfunction-Associated Fatty Liver Disease. International Journal of Environmental Research and Public Health 2021; 18(24): 13145 doi: 10.3390/ijerph182413145
|
| 10 |
Anna Egresi, Gabriella Lengyel, Krisztina Hagymási. Non-invasive assessment of fatty liver. Orvosi Hetilap 2015; 156(14): 543 doi: 10.1556/OH.2015.30123
|
| 11 |
Zoran Gluvic, Ratko Tomasevic, Ksenija Bojovic, Milan Obradovic, Esma R. Isenovic. Non-alcoholic fatty liver disease: a multidisciplinary clinical practice approach—the institutional adaptation to existing Clinical Practice Guidelines. Emergency and Critical Care Medicine 2022; 2(1): 12 doi: 10.1097/EC9.0000000000000016
|
| 12 |
David E. Amacher. Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease. Biomarkers 2014; 19(7): 541 doi: 10.3109/1354750X.2014.958535
|
| 13 |
Mary Cushman, Peter W. Callas, Kristine S. Alexander, Virginia Wadley, Neil A. Zakai, Steven D. Lidofsky, Frederick W. Unverzagt, Suzanne E. Judd, Nicholette D. Palmer. Nonalcoholic fatty liver disease and cognitive impairment: A prospective cohort study. PLOS ONE 2023; 18(4): e0282633 doi: 10.1371/journal.pone.0282633
|
| 14 |
Carlo Giorda, Gabriele Forlani, Roberta Manti, Natalia Mazzella, Salvatore De Cosmo, Maria Chiara Rossi, Antonio Nicolucci, Giuseppina Russo, Paolo Di Bartolo, Antonio Ceriello, Piero Guida. Occurrence over time and regression of nonalcoholic fatty liver disease in type 2 diabetes. Diabetes/Metabolism Research and Reviews 2017; 33(4) doi: 10.1002/dmrr.2878
|
| 15 |
Huili Wei, Hua Qu, Hang Wang, Huacong Deng. Associations between sitting time and non-alcoholic fatty liver diseases in Chinese male workers: a cross-sectional study. BMJ Open 2016; 6(9): e011939 doi: 10.1136/bmjopen-2016-011939
|
| 16 |
Rosa Martha Perez Gutierrez, Rita Valadez Romero. Effects of bixin in high-fat diet-fed-induced fatty liver in C57BL/6J mice. Asian Pacific Journal of Tropical Biomedicine 2016; 6(12): 1015 doi: 10.1016/j.apjtb.2016.09.006
|
| 17 |
Aynur Unalp‐Arida, Constance E. Ruhl. Liver fat scores predict liver disease mortality in the United States population. Alimentary Pharmacology & Therapeutics 2018; 48(9): 1003 doi: 10.1111/apt.14967
|
| 18 |
Fien de Boom, Ali Talib, Yvonne G. M. Roebroek, Givan F. Paulus, Ger H. Koek, Simon G. F. Robben, Bjorn Winkens, Nicole D. Bouvy, L. W. Ernest van Heurn. Non-Invasive Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease in Adolescents with Severe Obesity; Patient Characteristics and Association with Leptin—A Cross-Sectional Overview of Baseline Data from a RCT. Children 2024; 11(8): 965 doi: 10.3390/children11080965
|
| 19 |
Ioannis Ilias, Costas Thomopoulos. Non-alcoholic fatty liver disease, diabetes medications and blood pressure. World Journal of Diabetes 2021; 12(10): 1809-1811 doi: 10.4239/wjd.v12.i10.1809
|
| 20 |
Lei Xu, Jiarong Xie, Shenghui Chen, Yi Chen, Hua Yang, Min Miao, Zhongwei Zhu, Youming Li, Chaohui Yu, Chengfu Xu. Light-to-Moderate Alcohol Consumption Is Associated With Increased Risk of Type 2 Diabetes in Individuals With Nonalcoholic Fatty Liver Disease: A Nine-Year Cohort Study. American Journal of Gastroenterology 2020; 115(6): 876 doi: 10.14309/ajg.0000000000000607
|
| 21 |
Oumarou Nabi, Nathanaël Lapidus, Jerome Boursier, Victor de Ledinghen, Jean-Michel Petit, Sofiane Kab, Adeline Renuy, Marie Zins, Karine Lacombe, Lawrence Serfaty. Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study). Hepatology 2023; 78(1): 272 doi: 10.1097/HEP.0000000000000329
|
| 22 |
M.ª Teófila Vicente Herrero, M.ª Victoria Ramírez-Iñiguez de la Torre, Ángel Arturo López González. Obesidad, hábitos de vida y valoración FLI en la población laboral española durante la pandemia. Revista Clínica de Medicina de Familia 2022; : 93 doi: 10.55783/150205
|
| 23 |
Victoria T. Isaksen, Maria A. Larsen, Rasmus Goll, Jon R. Florholmen, Eyvind J. Paulssen. Hepatic steatosis, detected by hepatorenal index in ultrasonography, as a predictor of insulin resistance in obese subjects. BMC Obesity 2016; 3(1) doi: 10.1186/s40608-016-0118-0
|
| 24 |
Ehsaneh Taheri, Roberd M Bostick, Behzad Hatami, Mohammad Amin Pourhoseingholi, Hamid Asadzadeh Aghdaei, Alireza Moslem, Alireza Mousavi Jarrahi, Mohammad Reza Zali. Dietary and Lifestyle Inflammation Scores Are Inversely Associated with Metabolic-Associated Fatty Liver Disease among Iranian Adults: A Nested Case-Control Study. The Journal of Nutrition 2022; 152(2): 559 doi: 10.1093/jn/nxab391
|
| 25 |
Oscar Danielsson, Jana Nano, Katja Pahkala, Susanne Rospleszcz, Terho Lehtimäki, Christopher L. Schlett, Mika Kähönen, Fabian Bamberg, Olli Raitakari, Annette Peters, Markku J. Nissinen, Fredrik O. Åberg. Validity of fatty liver disease indices in the presence of alcohol consumption. Scandinavian Journal of Gastroenterology 2022; 57(11): 1349 doi: 10.1080/00365521.2022.2085060
|
| 26 |
Kengo Moriyama. Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Fatty Liver-Related Indices in a Japanese Population. Metabolic Syndrome and Related Disorders 2024; 22(3): 190 doi: 10.1089/met.2023.0212
|
| 27 |
Perspective review on solid-organ transplant: needs in point-of-care optical biomarkers. Journal of Biomedical Optics 2018; 23(08): 1 doi: 10.1117/1.JBO.23.8.080601
|
| 28 |
Sowbhikh Krishnan M, Sudha R. A STUDY OF NONALCOHOLIC FATTY LIVER DISEASE AND FATTY LIVER INDEX IN TYPE 2 DIABETES MELLITUS PATIENTS. Journal of Evidence Based Medicine and Healthcare 2016; 3(57): 3001 doi: 10.18410/jebmh/2016/654
|
| 29 |
|
| 30 |
Oumarou Nabi, Jerome Boursier, Karine Lacombe, Philippe Mathurin, Victor de Ledinghen, Marcel Goldberg, Marie Zins, Lawrence Serfaty. Comorbidities Are Associated with Fibrosis in NAFLD Subjects: A Nationwide Study (NASH-CO Study). Digestive Diseases and Sciences 2022; 67(6): 2584 doi: 10.1007/s10620-021-07032-z
|
| 31 |
Shira Zelber-Sagi, Dana Ivancovsky-Wajcman, Naomi Fliss Isakov, Muriel Webb, Dana Orenstein, Oren Shibolet, Revital Kariv. High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance. Journal of Hepatology 2018; 68(6): 1239 doi: 10.1016/j.jhep.2018.01.015
|
| 32 |
C. Vikneshwaran Chandra Kumar, Ruben Skantha, Wah-Kheong Chan. Non-invasive assessment of metabolic dysfunction–associated fatty liver disease. Therapeutic Advances in Endocrinology and Metabolism 2022; 13 doi: 10.1177/20420188221139614
|
| 33 |
Sabine Siegert, Zhonghao Yu, Rui Wang-Sattler, Thomas Illig, Jerzy Adamski, Jochen Hampe, Susanna Nikolaus, Stefan Schreiber, Michael Krawczak, Michael Nothnagel, Ute Nöthlings, Erica Villa. Diagnosing Fatty Liver Disease: A Comparative Evaluation of Metabolic Markers, Phenotypes, Genotypes and Established Biomarkers. PLoS ONE 2013; 8(10): e76813 doi: 10.1371/journal.pone.0076813
|
| 34 |
Vlad Ratziu. Clinical Dilemmas in Non‐Alcoholic Fatty Liver Disease. 2016; : 111 doi: 10.1002/9781118924938.ch13
|
| 35 |
Simone Jacobs, Susanne Jäger, Eugene Jansen, Andreas Peter, Norbert Stefan, Heiner Boeing, Matthias B. Schulze, Janine Kröger, Hervé Guillou. Associations of Erythrocyte Fatty Acids in the De Novo Lipogenesis Pathway with Proxies of Liver Fat Accumulation in the EPIC-Potsdam Study. PLOS ONE 2015; 10(5): e0127368 doi: 10.1371/journal.pone.0127368
|
| 36 |
C. E. Ruhl, J. E. Everhart. Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey. Alimentary Pharmacology & Therapeutics 2015; 41(1): 65 doi: 10.1111/apt.13012
|
| 37 |
Yuriko Matsushita, Yutaka Hasegawa, Noriko Takebe, Ken Onodera, Masaharu Shozushima, Tomoyasu Oda, Kan Nagasawa, Hiroyuki Honma, Koji Nata, Akira Sasaki, Yasushi Ishigaki. Serum C‐X‐C motif chemokine ligand 14 levels are associated with serum C‐peptide and fatty liver index in type 2 diabetes mellitus patients. Journal of Diabetes Investigation 2021; 12(6): 1042 doi: 10.1111/jdi.13438
|
| 38 |
M.S. Abdelbary, R. Marzaban, H. Gamal Eldeen, M. Khairy, M. Menesy, M.H. Fahmy, A.M. Ayad, B.S. Mouheb, A. Yosry. Clinical utility of transient elastography as an imaging tool to assess the short-term impact of laparoscopic sleeve gastrectomy, together with clinical and biochemical parameters and clinico-biochemical indices, on obese patients with nonalcoholic fatty liver disease: An Egyptian pilot study. Revista de Gastroenterología de México (English Edition) 2021; 86(2): 125 doi: 10.1016/j.rgmxen.2020.04.008
|
| 39 |
Aleksandra Klisic, Nebojsa Kavaric, Ana Ninic. Predictive values of serum uric acid and Alanine-aminotransferase for fatty liver index in Montenegrin population. Journal of Medical Biochemistry 2019; 38(4): 407 doi: 10.2478/jomb-2019-0001
|
| 40 |
Yi-Shu Chen, Dan Chen, Chao Shen, Ming Chen, Chao-Hui Jin, Cheng-Fu Xu, Chao-Hui Yu, You-Ming Li. A novel model for predicting fatty liver disease by means of an artificial neural network. Gastroenterology Report 2021; 9(1): 31 doi: 10.1093/gastro/goaa035
|
| 41 |
Takumi Nishi, Akira Babazono, Toshiki Maeda, Takuya Imatoh, Hiroshi Une. Evaluation of the fatty liver index as a predictor for the development of diabetes among insurance beneficiaries with prediabetes. Journal of Diabetes Investigation 2015; 6(3): 309 doi: 10.1111/jdi.12290
|
| 42 |
Aleksandra Klisic, Nebojsa Kavaric, Ludovico Abenavoli, Verica Stanisic, Vesna Spasojevic-Kalimanovska, Jelena Kotur-Stevuljevic, Ana Ninic. Is endocan a novel potential biomarker of liver steatosis and fibrosis?. Journal of Medical Biochemistry 2019; 0(0) doi: 10.2478/jomb-2019-0042
|
| 43 |
Hyemi Kwon, Kyung-Do Han, Sun Joon Moon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee. Nonalcoholic Fatty Liver Disease and the Risk of Thyroid Cancer Among Young Adults in South Korea. The Journal of Clinical Endocrinology & Metabolism 2024; 109(3): e1095 doi: 10.1210/clinem/dgad575
|
| 44 |
So-Ryoung Lee, Kyung-Do Han, Eue-Keun Choi, Seil Oh, Gregory Y. H. Lip. Nonalcoholic fatty liver disease and the risk of atrial fibrillation stratified by body mass index: a nationwide population-based study. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83367-x
|
| 45 |
Fragkiskos G. Bersimis, Iraklis Varlamis. Classification Techniques for Medical Image Analysis and Computer Aided Diagnosis. 2019; : 31 doi: 10.1016/B978-0-12-818004-4.00002-9
|
| 46 |
Joo-Hyun Park, Jung Yong Hong, Kyungdo Han, Wonseok Kang, Joo Kyung Park. Increased risk of pancreatic cancer in individuals with non-alcoholic fatty liver disease. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-14856-w
|
| 47 |
Kena Zhou, Jie Cen. RETRACTED ARTICLE: The fatty liver index (FLI) and incident hypertension: a longitudinal study among Chinese population. Lipids in Health and Disease 2018; 17(1) doi: 10.1186/s12944-018-0858-6
|
| 48 |
M.ª Teófila Vicente-Herrero, M.ª Victoria Ramírez-Iñiguez de la Torre, Ángel Arturo López González. Obesidad, hábitos de vida y valoración FLI en la población laboral española durante la pandemia. Revista Clínica de Medicina de Familia 2022; : 93 doi: 10.55783/rcmf.150205
|
| 49 |
Teodora Biciusca, Sorina Ionelia Stan, Mara Amalia Balteanu, Ramona Cioboata, Alice Elena Ghenea, Suzana Danoiu, Ana-Maria Bumbea, Viorel Biciusca. The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review. Diagnostics 2023; 13(21): 3316 doi: 10.3390/diagnostics13213316
|
| 50 |
Laura M. Breij, Gerthe F. Kerkhof, Anita C. S. Hokken-Koelega. Accelerated Infant Weight Gain and Risk for Nonalcoholic Fatty Liver Disease in Early Adulthood. The Journal of Clinical Endocrinology & Metabolism 2014; 99(4): 1189 doi: 10.1210/jc.2013-3199
|
| 51 |
Oumarou Nabi, Nathanaël Lapidus, Jerome Boursier, Victor de Ledinghen, Sofiane Kab, Adeline Renuy, Marie Zins, Lawrence Serfaty, Karine Lacombe. The NAFLD burden on mortality and morbidities in general population: A community‐based longitudinal study (NASH‐CO study). Liver International 2023; 43(10): 2096 doi: 10.1111/liv.15674
|
| 52 |
Raluca Pais, Elena Rusu, Diana Zilisteanu, Alexandra Circiumaru, Laurentiu Micu, Mihai Voiculescu, Thierry Poynard, Vlad Ratziu. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease. European Journal of Internal Medicine 2015; 26(1): 30 doi: 10.1016/j.ejim.2014.12.001
|
| 53 |
Ji Hye Huh, Song Vogue Ahn, Sang Baek Koh, Eunhee Choi, Jang Young Kim, Ki-Chul Sung, Eung Ju Kim, Jeong Bae Park, Vincent Wong. A Prospective Study of Fatty Liver Index and Incident Hypertension: The KoGES-ARIRANG Study. PLOS ONE 2015; 10(11): e0143560 doi: 10.1371/journal.pone.0143560
|
| 54 |
William N. Evans, Ruben J. Acherman, Michael L. Ciccolo, Sergio A. Carrillo, Alvaro Galindo, Abraham Rothman, Gary A. Mayman, Elizabeth A. Adams, Leigh C. Reardon, Brody J. Winn, Noel S. Yumiaco, Lesley Shimuizu, Yoko Inanaga, Rowena J. Deleon, Humberto Restrepo. A composite noninvasive index correlates with liver fibrosis scores in post-Fontan patients: Preliminary findings. Congenital Heart Disease 2018; 13(1): 38 doi: 10.1111/chd.12558
|
| 55 |
Hwi Jin Im, Yo Chan Ahn, Jing-Hua Wang, Myung Min Lee, Chang Gue Son. Systematic review on the prevalence of nonalcoholic fatty liver disease in South Korea. Clinics and Research in Hepatology and Gastroenterology 2021; 45(4): 101526 doi: 10.1016/j.clinre.2020.06.022
|
| 56 |
Kristine S. Alexander, Neil A. Zakai, Steven D. Lidofsky, Peter W. Callas, Suzanne E. Judd, Russell P. Tracy, Mary Cushman, Pavel Strnad. Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort. PLOS ONE 2018; 13(3): e0194153 doi: 10.1371/journal.pone.0194153
|
| 57 |
Peter Dietrich, Claus Hellerbrand. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best Practice & Research Clinical Gastroenterology 2014; 28(4): 637 doi: 10.1016/j.bpg.2014.07.008
|
| 58 |
Jiyun Park, Gyuri Kim, Bong-Sung Kim, Kyung-Do Han, So Yoon Kwon, So Hee Park, You-Bin Lee, Sang-Man Jin, Jae Hyeon Kim. The association between changes in hepatic steatosis and hepatic fibrosis with cardiovascular outcomes and mortality in patients with New-Onset type 2 Diabetes: A nationwide cohort study. Diabetes Research and Clinical Practice 2022; 194: 110191 doi: 10.1016/j.diabres.2022.110191
|
| 59 |
Yong Zhang, Chao Wang, Yangyang Duanmu, Chenxin Zhang, Wei Zhao, Ling Wang, Xiaoguang Cheng, Nicola Veronese, Giuseppe Guglielmi. Comparison of CT and magnetic resonance mDIXON-Quant sequence in the diagnosis of mild hepatic steatosis. The British Journal of Radiology 2018; 91(1091): 20170587 doi: 10.1259/bjr.20170587
|
| 60 |
Swati Ghonge, Sai Mahesh Vajjala. Advancing insights into non-alcoholic fatty liver disease: A critical analysis of ultrasonography and beyond. Journal of Family Medicine and Primary Care 2024; 13(8): 3461 doi: 10.4103/jfmpc.jfmpc_419_24
|
| 61 |
Hyun Hee Lee, Han Ro, Ji Yong Jung, Jae Hyun Chang, Wookyung Chung, Ae Jin Kim. The Fatty Liver Index’s Association with Incident Chronic Kidney Disease in Korean Middle-Aged Adults: A Community-Based Cohort Study. Journal of Clinical Medicine 2024; 13(6): 1616 doi: 10.3390/jcm13061616
|
| 62 |
Ji Hye Huh, Jang Young Kim, Eunhee Choi, Jae Seok Kim, Yoosoo Chang, Ki-Chul Sung, Tatsuo Shimosawa. The fatty liver index as a predictor of incident chronic kidney disease in a 10-year prospective cohort study. PLOS ONE 2017; 12(7): e0180951 doi: 10.1371/journal.pone.0180951
|
| 63 |
Petar Avramovski, Maja Avramovska, Zorica Nikleski, Biljana Ilkovska, Kosta Sotiroski, Emilija Sikole. The predictive value of the hepatorenal index for detection of impaired glucose metabolism in patients with non-alcoholic fatty liver disease. Indian Journal of Gastroenterology 2020; 39(1): 50 doi: 10.1007/s12664-019-01009-7
|
| 64 |
Kwang Baek Kim, Gwang Ha Kim, Doo Heon Song, Hyun Jun Park, Chang Won Kim. Automatic segmentation of liver/kidney area with double-layered fuzzy C-means and the utility of hepatorenal index for fatty liver severity classification. Journal of Intelligent & Fuzzy Systems 2020; 39(1): 925 doi: 10.3233/JIFS-191850
|
| 65 |
Luca Montesi, Chiara Caselli, Elena Centis, Chiara Nuccitelli, Simona Moscatiello, Alessandro Suppini, Giulio Marchesini. Physical activity support or weight loss counseling for nonalcoholic fatty liver disease?. World Journal of Gastroenterology 2014; 20(29): 10128-10136 doi: 10.3748/wjg.v20.i29.10128
|
| 66 |
Giovanni Tarantino. NAFLD or MAFLD: That is the conundrum. Hepatobiliary & Pancreatic Diseases International 2022; 21(2): 103 doi: 10.1016/j.hbpd.2022.01.008
|
| 67 |
Eun Kyung Choe, Hae Yeon Kang. The association between platelet-related parameters and nonalcoholic fatty liver disease in a metabolically healthy nonobese population. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-56796-7
|
| 68 |
Xiuqi Qiao, Xiaoxia Wang, Lixin Guo, Qi Pan. Excessive Daytime Napping Increases the Risk of Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and a Mendelian Randomization Study. Nature and Science of Sleep 2024; : 1067 doi: 10.2147/NSS.S468444
|
| 69 |
Dariusz Narankiewicz, Josefina Ruiz-Nava, Veronica Buonaiuto, María Isabel Ruiz-Moreno, María Dolores López-Carmona, Luis Miguel Pérez-Belmonte, Ricardo Gómez-Huelgas, María Rosa Bernal-López. Utility of Liver Function Tests and Fatty Liver Index to Categorize Metabolic Phenotypes in a Mediterranean Population. International Journal of Environmental Research and Public Health 2020; 17(10): 3518 doi: 10.3390/ijerph17103518
|
| 70 |
Marco Castellana, Rossella Donghia, Vito Guerra, Filippo Procino, Luisa Lampignano, Fabio Castellana, Roberta Zupo, Rodolfo Sardone, Giovanni De Pergola, Francesco Romanelli, Pierpaolo Trimboli, Gianluigi Giannelli. Performance of Fatty Liver Index in Identifying Non-Alcoholic Fatty Liver Disease in Population Studies. A Meta-Analysis. Journal of Clinical Medicine 2021; 10(9): 1877 doi: 10.3390/jcm10091877
|
| 71 |
Daljeet Chahal, Divya Sharma, Sareh Keshavarzi, Fakhar Ali Qazi Arisar, Keyur Patel, Wei Xu, Mamatha Bhat. Distinctive clinical and genetic features of lean vs overweight fatty liver disease using the UK Biobank. Hepatology International 2022; 16(2): 325 doi: 10.1007/s12072-022-10304-z
|
| 72 |
Meng-Tzu Weng, Po-Jen Yang, Pan-Fu Liu, Chin-Hao Chang, Hsuan-Shu Lee, Jin-Chuan Sheu, Hsiao-Ching Nien. Effects of dapagliflozin on liver steatosis in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Hepatology International 2024; doi: 10.1007/s12072-024-10758-3
|
| 73 |
Sebastiaan Boone, Dennis Mook-Kanamori, Frits Rosendaal, Martin den Heijer, Hildo Lamb, Albert de Roos, Saskia le Cessie, Ko Willems van Dijk, Renée de Mutsert. Metabolomics: a search for biomarkers of visceral fat and liver fat content. Metabolomics 2019; 15(10) doi: 10.1007/s11306-019-1599-x
|
| 74 |
Adam J. Buckley, E. Louise Thomas, Nader Lessan, Francesca M. Trovato, Guglielmo M. Trovato, Simon D. Taylor-Robinson. Non-alcoholic fatty liver disease: Relationship with cardiovascular risk markers and clinical endpoints. Diabetes Research and Clinical Practice 2018; 144: 144 doi: 10.1016/j.diabres.2018.08.011
|
| 75 |
Saman Khalatbari-Soltani, Pedro Marques-Vidal, Fumiaki Imamura, Nita G. Forouhi. Prospective association between adherence to the Mediterranean diet and hepatic steatosis: the Swiss CoLaus cohort study. BMJ Open 2020; 10(12): e040959 doi: 10.1136/bmjopen-2020-040959
|
| 76 |
Xiaomin Hua, Yanjun Sun, Yingjie Zhong, Wenhuan Feng, Hong Huang, Weimin Wang, Tianyan Zhang, Yun Hu. Low serum sex hormone‐binding globulin is associated with nonalcoholic fatty liver disease in type 2 diabetic patients. Clinical Endocrinology 2014; 80(6): 877 doi: 10.1111/cen.12360
|
| 77 |
M.S. Abdelbary, R. Marzaban, H. Gamal Eldeen, M. Khairy, M. Menesy, M.H. Fahmy, A.M. Ayad, B.S. Mouheb, A. Yosry. La utilidad clínica de la elastografía transitoria como una herramienta de imagenología para evaluar el impacto a corto plazo de la gastrectomía laparoscópica en manga, en conjunto con parámetros clínicos y bioquímicos e índices clínico-bioquímicos en pacientes con enfermedad de hígado graso no alcohólico: un estudio piloto egipcio. Revista de Gastroenterología de México 2021; 86(2): 125 doi: 10.1016/j.rgmx.2020.04.007
|
| 78 |
Takumi Nishi, Akira Babazono, Toshiki Maeda, Takuya Imatoh, Hiroshi Une. Effects of Eating Fast and Eating Before Bedtime on the Development of Nonalcoholic Fatty Liver Disease. Population Health Management 2016; 19(4): 279 doi: 10.1089/pop.2015.0088
|
| 79 |
SamimAli Mondal, Deep Dutta, Manoj Kumar, Pankaj Singh, Madhurima Basu, Chitra Selvan, Satinath Mukhopadhyay. Neck circumference to height ratio is a reliable predictor of liver stiffness and nonalcoholic fatty liver disease in prediabetes. Indian Journal of Endocrinology and Metabolism 2018; 22(3): 347 doi: 10.4103/ijem.IJEM_31_18
|
| 80 |
E. Lerchbaum, S. Pilz, T.B. Grammer, B.O. Boehm, T. Stojakovic, B. Obermayer-Pietsch, W. März. The fatty liver index is associated with increased mortality in subjects referred to coronary angiography. Nutrition, Metabolism and Cardiovascular Diseases 2013; 23(12): 1231 doi: 10.1016/j.numecd.2013.02.004
|
| 81 |
Alessandra Carvalho Goulart, Ilka Regina Souza de Oliveira, Airlane Pereira Alencar, Maira Solange Camara dos Santos, Itamar Souza Santos, Brenda Margatho Ramos Martines, Danilo Peron Meireles, João Augusto dos Santos Martines, Giovanni Misciagna, Isabela Martins Benseñor, Paulo Andrade Lotufo. Diagnostic accuracy of a noninvasive hepatic ultrasound score for non-alcoholic fatty liver disease (NAFLD) in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Sao Paulo Medical Journal 2015; 133(2): 115 doi: 10.1590/1516-3180.2014.9150812
|
| 82 |
Kristina Blaslov, Karin Zibar, Tomislav Bulum, Lea Duvnjak. Effect of exenatide therapy on hepatic fat quantity and hepatic biomarkers in type 2 diabetic patients. Clinics and Research in Hepatology and Gastroenterology 2014; 38(3): e61 doi: 10.1016/j.clinre.2013.10.013
|
| 83 |
A Lum Han. Association between metabolic associated fatty liver disease and osteoarthritis using data from the Korean national health and nutrition examination survey (KNHANES). Inflammopharmacology 2021; 29(4): 1111 doi: 10.1007/s10787-021-00842-7
|
| 84 |
Yunyi Yang, Xiaoli He, Shufa Tan, Xiaoxiao Qu, Weijin Huang, Jiayuan Cai, Jiawen You, Xinyi Fu, Yanming He, Hongjie Yang. The association between immunoinflammatory biomarkers NLR, PLR, LMR and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-024-01539-1
|
| 85 |
Nevine I. Musa, Eslam Safwat, Sara M. Abdelhakam, Amir M. Farid, Waleed M. Hetta. Noninvasive tool for the diagnosis of NAFLD in association with atherosclerotic cardiovascular risk. Egyptian Liver Journal 2019; 9(1) doi: 10.1186/s43066-019-0002-y
|
| 86 |
Xiangliang Liu, Yu Chang, Feng Jia, Yuguang Li, Yao Wang, Jiuwei Cui. Association of Life’s Essential 8 with metabolic dysfunction-associated steatotic liver disease (MASLD), a cross-sectional study from the NHANES 2003–2018. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-67728-w
|
| 87 |
Joo-Hyun Park, Jung Yong Hong, Minsuk Kwon, Jiyun Lee, Kyungdo Han, In Woong Han, Wonseok Kang, Joo Kyung Park. Association between non-alcoholic fatty liver disease and the risk of biliary tract cancers: A South Korean nationwide cohort study. European Journal of Cancer 2021; 150: 73 doi: 10.1016/j.ejca.2021.03.024
|
| 88 |
A. Rivera-Andrade, M.F. Kroker-Lobos, M. Lazo, N.D. Freedman, J.W. Smith, O. Torres, K.A. McGlynn, J.D. Groopman, E. Guallar, M. Ramirez-Zea. High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based study. Nutrition, Metabolism and Cardiovascular Diseases 2019; 29(2): 191 doi: 10.1016/j.numecd.2018.10.008
|
| 89 |
Hua Qu, Hang Wang, Min Deng, Huili Wei, Huacong Deng, Partha Mukhopadhyay. Associations between Longer Habitual Day Napping and Non-Alcoholic Fatty Liver Disease in an Elderly Chinese Population. PLoS ONE 2014; 9(8): e105583 doi: 10.1371/journal.pone.0105583
|
| 90 |
Shinsuke Nirengi, Mami Fujibayashi, Sachiko Furuno, Akihiko Uchibe, Yasuharu Kawase, Shin Sukino, Yaeko Kawaguchi, Satomi Minato, Kazuhiko Kotani, Naoki Sakane. Nonalcoholic Fatty Liver Disease in University Rugby Football Players. Frontiers in Endocrinology 2018; 9 doi: 10.3389/fendo.2018.00341
|
| 91 |
Nitin Kapoor, Jennifer Audsley, Priscilla Rupali, Joe Sasadeusz, Thomas V. Paul, Nihal Thomas, Sharon R. Lewin. A gathering storm. AIDS 2019; 33(7): 1105 doi: 10.1097/QAD.0000000000002161
|
| 92 |
Masashi Hirooka, Yohei Koizumi, Kotarou Sunago, Yoshiko Nakamura, Kana Hirooka, Takao Watanabe, Osamu Yoshida, Yoshio Tokumoto, Masanori Abe, Yoichi Hiasa. Efficacy of B-mode ultrasound-based attenuation for the diagnosis of hepatic steatosis: a systematic review/meta-analysis. Journal of Medical Ultrasonics 2022; 49(2): 199 doi: 10.1007/s10396-022-01196-5
|
| 93 |
Oumarou Nabi, Jerome Boursier, Nathanaël Lapidus, Philippe Mathurin, Victor de Ledinghen, Jean‐Michel Petit, Marcel Goldberg, Marie Zins, Karine Lacombe, Lawrence Serfaty. The burden of NAFLD in type 2 diabetic subjects from the general population: A Nationwide population‐based follow‐up study (NASHCO). Liver International 2022; 42(3): 595 doi: 10.1111/liv.15171
|
| 94 |
Mojdeh Fathi, Pezhman Alavinejad, Zahra Haidari, Reza Amani. The Effect of Zinc Supplementation on Steatosis Severity and Liver Function Enzymes in Overweight/Obese Patients with Mild to Moderate Non-alcoholic Fatty Liver Following Calorie-Restricted Diet: a Double-Blind, Randomized Placebo-Controlled Trial. Biological Trace Element Research 2020; 197(2): 394 doi: 10.1007/s12011-019-02015-8
|
| 95 |
Meagan Rose, Martin Veysey, Mark Lucock, Suzanne Niblett, Katrina King, Surinder Baines, Manohar L. Garg. Association between erythrocyte omega-3 polyunsaturated fatty acid levels and fatty liver index in older people is sex dependent. Journal of Nutrition & Intermediary Metabolism 2016; 5: 78 doi: 10.1016/j.jnim.2016.04.007
|
| 96 |
Muhammad Amjad Pervez, Dilshad Ahmed Khan, Atiq Ur Rehman Slehria, Aamir Ijaz. Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial. Complementary Therapies in Medicine 2020; 52: 102494 doi: 10.1016/j.ctim.2020.102494
|
| 97 |
Alessandro Leone, Alberto Battezzati, Giorgio Bedogni, Laila Vignati, Angelo Vanzulli, Ramona De Amicis, Andrea Foppiani, Simona Bertoli. Sex- and Age-Related Differences in the Contribution of Ultrasound-Measured Visceral and Subcutaneous Abdominal Fat to Fatty Liver Index in Overweight and Obese Caucasian Adults. Nutrients 2019; 11(12): 3008 doi: 10.3390/nu11123008
|
| 98 |
Hilmar K Lückhoff, Frederik C Kruger, Maritha J Kotze. Composite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countries. World Journal of Hepatology 2015; 7(9): 1192-1208 doi: 10.4254/wjh.v7.i9.1192
|
| 99 |
Orit Goldman, Ofir Ben-Assuli, Ori Rogowski, David Zeltser, Itzhak Shapira, Shlomo Berliner, Shira Zelber-Sagi, Shani Shenhar-Tsarfaty. Non-alcoholic Fatty Liver and Liver Fibrosis Predictive Analytics: Risk Prediction and Machine Learning Techniques for Improved Preventive Medicine. Journal of Medical Systems 2021; 45(2) doi: 10.1007/s10916-020-01693-5
|
| 100 |
Hykoush A. Asaturyan, Nicolas Basty, Marjola Thanaj, Brandon Whitcher, E. Louise Thomas, Jimmy D. Bell, Ferdinando Carlo Sasso. Improving the accuracy of fatty liver index to reflect liver fat content with predictive regression modelling. PLOS ONE 2022; 17(9): e0273171 doi: 10.1371/journal.pone.0273171
|